Evidence map›Paper›PMID 22264087›Full record

ArticleAIDS research and human retroviruses2012

No increase of drug-resistant HIV type 1 prevalence among drug-naive individuals in Northern Vietnam.

Vuong Thi Tran, Azumi Ishizaki, Cuong Hung Nguyen, Huyen Thi Thanh Hoang, Hung Viet Pham, Xiuqiong Bi, Thuc Van Pham, Hiroshi Ichimura

Open access · greenAbstract read
In one paragraph

Article in AIDS research and human retroviruses, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. An action agenda for HIV and sex workers.Lancet (London, England) · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Vuong Thi TranDepartment of Viral Infection and International Health, Graduate School of Medical Science, Kanazawa University, Japan.
Azumi Ishizaki
Cuong Hung Nguyen
Huyen Thi Thanh Hoang
Hung Viet Pham
Xiuqiong Bi
Thuc Van Pham
Hiroshi Ichimura
Kanazawa University · JPHai phong University Of Medicine and Pharmacy · VN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We reported previously that the prevalence of drug-resistant HIV-1 among antiretroviral therapy (ART)-naive individuals in Northern Vietnam was 2.9% in 2007 and 6.2% in 2008. To investigate the continuing trend of prevalence, we collected plasma samples from 958 individuals in Hai Phong and Hanoi in 2009, extracted viral RNA from HIV-1 antibody-positive samples, and analyzed them genetically. HIV-1 antibody prevalence was 26.8% in injecting drug users (n=302), 13.4% in female sex workers (n=284), 0.5% in blood donors (n=206), and 0.6% in pregnant women (n=166). All HIV-1 strains were CRF01_AE. Nonnucleoside reverse-transcriptase inhibitor resistance mutations were found in two (2.0%) of the 102 successfully analyzed cases (one case with the Y181C and one with the K101E). No nucleoside reverse-transcriptase inhibitor resistance or protease inhibitor resistance mutations were detected. The prevalence of circulating ART-resistant HIV-1 in Northern Vietnam did not increase from 2007 to 2009, although the rate of ART coverage did increase.

Indexed as

AdultBlood DonorsDrug Resistance, ViralDrug UsersFemaleGenotypeHIV-1HIV Protease InhibitorsHIV SeropositivityHumansMaleMolecular Sequence DataMutation, MissensePhylogenypol Gene Products, Human Immunodeficiency VirusPregnancyHIV Protease Inhibitorspol Gene Products, Human Immunodeficiency VirusReverse Transcriptase InhibitorsRNA, Viral

Identifiers

PMID22264087
PMCPMC3448096
OpenAlexW1989920933

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.